UNSPSC 51351601: 16-epiestriol

This classification denotes a steroidal estrogen with the molecular formula C18H24O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8XZ32LI44K, chemically known as 3,16beta,17beta-trihydroxy-1,3,5(10)-estratriene but generally known as 16-epiestriol, which bears US NIH Compound Identifier 3269. European Medicines Agency schedules Epiestriol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06565MIG.

The term EPIESTRIOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). SMILES: CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O.

UNSPSC 51351601 Epiestriol is a Commodity code that represents a specific pharmaceutical compound used in hormone replacement therapy and related clinical applications. State and local procurement activity under this code reflects purchases of epiestriol as a finished pharmaceutical product or active pharmaceutical ingredient for use in government-operated or government-supported healthcare facilities, clinics, and public health programs. The code sits within the broader Family of pharmaceutical products and active ingredients that state health departments, county health systems, municipal hospitals, and public health agencies source for clinical inventory and patient treatment.

The source material provided contains no recent state or local contract opportunities tagged to this code, making it impossible to characterize current issuing-body patterns, geographic concentration, or representative solicitation activity. Without posted RFP, RFQ, IFB, or ITB notices identifying specific jurisdictions, dollar volumes, or response dates, no actionable market signal can be drawn for business development purposes at this time.